-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2022qdr-datasources.pdf
December 01, 2022 - Data are also available at CDC, National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention … B vaccine (Hep B); varicella zoster vaccine; pneumococcal conjugate vaccine (PCV);
hepatitis A (Hep … , home health agencies have been required to collect a revised version
of the OASIS dataset (OASIS-C) … OASIS-C includes data items supporting measurement of rates
https://www.cms.gov/
https://www.cms.gov … Sylvester J, Blankenship C, Carter A, et al.
-
www.ahrq.gov/research/findings/final-reports/stpra/stpraexh9.html
April 01, 2018 - Database Analysis
Appendix C. Site Visit Protocol
Appendix D.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023qdr-data-sources.pdf
December 01, 2023 - Data are also available at CDC, National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention … vaccine;
measles, mumps, and rubella vaccine (MMR); Haemophilus influenzae type B vaccine (Hib);
hepatitis … , home health agencies have been required to collect a revised version
of the OASIS dataset (OASIS-C) … OASIS-C includes data items supporting measurement of rates
for use of specific evidence-based care … Sylvester J, Blankenship C, Carter A, et al.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2018qdr-datasources.pdf
October 01, 2019 - B vaccine (Hep B); varicella zoster vaccine; pneumococcal conjugate vaccine (PCV);
hepatitis A (Hep … , home health agencies have been required to collect a revised version
of the OASIS dataset (OASIS-C) … OASIS-C includes data items supporting measurement of rates
for use of specific evidence-based care … Sylvester J, Blankenship C, Carter A, et al. … Zhan C, Elixhauser A, Richards CL Jr, et al.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-datasources.pdf
December 01, 2020 - vaccine;
measles, mumps, and rubella vaccine (MMR); Haemophilus influenzae type B vaccine (Hib);
hepatitis … , home health agencies have been required to collect a revised
version of the OASIS dataset (OASIS-C) … OASIS-C includes data items supporting
measurement of rates for use of specific evidence-based care … Sylvester J, Blankenship C, Carter A, et al. … Zhan C, Elixhauser A, Richards CL Jr, et al.
-
www.ahrq.gov/research/findings/final-reports/ptfamilyscan/ptfamilyex2.html
July 01, 2018 - Appendix A: Draft Key Informant Interview Protocol
Appendix B: Summary of Search Terms
Appendix C:
-
www.ahrq.gov/ncepcr/care/coordination/atlas/appendix3.html
June 01, 2014 - Director, Western New York Care Coordination Program, c/o Coordinated Care Services, Inc.
-
www.ahrq.gov/hai/quality/tools/cauti-ltc/modules/resources/guides/infection-prevent.html
March 01, 2017 - MRSA (methicillin-resistant Staphylococcus aureus )
VRE (vancomycin-resistant Enterococcus )
C. … MRSA (methicillin-resistant Staphylococcus aureus )
VRE (vancomycin-resistant Enterococcus )
C. … the resident, including—
Nausea
Diarrhea
Allergic reactions
Antibiotic-related infection ( C. … These work practices include—
Offering the hepatitis B vaccine to any staff member who has the potential
-
www.ahrq.gov/research/findings/final-reports/stpra/stpraapamattabs.html
April 01, 2018 - Database Analysis
Appendix C. Site Visit Protocol
Appendix D.
-
www.ahrq.gov/ncepcr/tools/workforce-financing/case-example-7.html
July 01, 2019 - For example, a patient might be a candidate for treatment for hepatitis C, but not if they are drinking
-
www.ahrq.gov/ncepcr/care/coordination/atlas/chapter6e.html
June 01, 2014 - Information transfer:
Between health care professional(s) and patient/family: 1.4, 2.2A, 4.2E, 6.1A-C, … Participants not specified: 4.2F
Facilitate transitions:
As coordination needs change: 4.1A-C, … and patient/family: I.39d-g
Within teams of health care professionals: I.5, I.17, I.35, I.312a-c,
-
www.ahrq.gov/practiceimprovement/delivery-initiative/rodriguez/index.html
December 01, 2020 - Medical Assistant intervention arm has 8.4% point improvement in LDL-C control. … Slide 25
Outcomes Summary
Clinical Outcomes:
Improved LDL-C control for the MA arm (8.4% … Key Conclusions
Diabetic patients improved intermediate outcomes (Blood pressure for CHW; LDL-C
-
www.ahrq.gov/research/findings/final-reports/ptfamilyscan/ptfamilyapb.html
July 01, 2018 - Appendix A: Draft Key Informant Interview Protocol
Appendix B: Summary of Search Terms
Appendix C:
-
www.ahrq.gov/sites/default/files/wysiwyg/funding/training-grants/kaward/kaward-evalreport.pdf
August 01, 2016 - Suggested Citation:
Erickson C, Spitzer T, Shaheen M, et al. … AHRQ K Award applicants resubmitted an application; of these, 31 percent were
funded (see Appendix C) … percent of respondents were either satisfied (33
percent) or very satisfied (52 percent) (Appendix C) … Medicine
Journal of Urban Health
Journal of Urology
Journal of Vascular Surgery
Journal of Viral Hepatitis … AHRQ K Program Grantee Questionnaire
Appendix C. Additional Data Referenced in Report
Appendix D.
-
www.ahrq.gov/research/findings/final-reports/ptmgmt/references.html
September 01, 2018 - Wexler R, Bean C, Ito D, et al. … Bodenheimer T, MacGregor K, Sharifi C. Helping patients manage their chronic conditions.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE-rev.pdf
January 01, 2023 - A-18
Appendix C. … C-1
Quality Map .................................................................................... … C-11
Appendix D. … 1
Appendix C. … measles-mumps-rubella vaccine
NIS 2021
Children ages 19-35 months who received 3 or more doses of
hepatitis
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE.pdf
January 01, 2023 - A-18
Appendix C. … C-1
Quality Map .................................................................................... … C-11
Appendix D. … 1
Appendix C. … measles-mumps-rubella vaccine
NIS 2021
Children ages 19-35 months who received 3 or more doses of
hepatitis
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2022qdr-appendix-combined.pdf
October 25, 2022 - A-17
Appendix C. … ....................................................................................................C- … ....................................................................................................C- … APPENDIX C. … measles-mumps-rubella vaccine NIS 2020
Children ages 19-35 months who received 3 or more doses of
hepatitis
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/case_example_7.pdf
October 01, 2016 - For example, a patient might be a candidate for
treatment for hepatitis C, but not if they are drinking
-
www.ahrq.gov/research/findings/final-reports/stpra/stpra1.html
April 01, 2018 - Database Analysis
Appendix C. Site Visit Protocol
Appendix D.